InvestorsHub Logo
Followers 38
Posts 1440
Boards Moderated 0
Alias Born 03/07/2004

Re: cheynew post# 193067

Wednesday, 10/08/2014 4:00:49 PM

Wednesday, October 08, 2014 4:00:49 PM

Post# of 346054
chey, actually, unbelievable. Your reference quoted: "Our data show that the PS-targeting mAb PGN632 is at least equally efficacious compared with Zirgan® in reducing corneal SLE (slit lamp evaluation) scores and minimizing the ocular clinical symptoms. By providing symptomatic relief in addition to reducing corneal SLE scores, PGN632 could become a drug of choice for treatment of ocular herpes. This herpes corneal treatment for PGN632 is big too. Was this info. posted here previously? I am jazzed! (for a change).
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News